Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma

NCT02867618 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped PI left institution

Conditions

Hodgkin Disease
Lymphoma, Non-hodgkin

Interventions

DRUG: Carfilzomib
DRUG: TGR-1202

Sponsor

Columbia University